CASI Pharmaceuticals, Inc. Soared
Thu, Jun 27, 2024 at 07:29 PM
CASI Pharmaceuticals, Inc. (CASI:NASDAQ) shot up at $4.9, representing a gain of 37.3%. On Thu, Jun 27, 2024, CASI:NASDAQ hit a New 2-Week High of $4.9. The stock got featured on our News Catalysts scanner on Thu, Jun 27, 2024 at 12:46 PM in the 'ACQUISITION' category. From Thu, Jun 13, 2024, the stock recorded 44.44% Up Days and 50.00% Green Days
About CASI Pharmaceuticals, Inc. (CASI:NASDAQ)
CASI Pharmaceuticals Inc is engaged in research and development of biopharmaceutical products. It mainly focuses on acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs.
Top 10 Gainers:
- Vinco Ventures Inc. (BBIG:NASDAQ), 100%
- Assure Holdings Corp. (IONM:NASDAQ), 82.76%
- Inspire Veterinary Partners Inc. (IVP:NASDAQ), 64.44%
- XBP Europe Holdings Inc. (XBP:NASDAQ), 58.2%
- Denali Capital Acquisition Corp. (DECA:NASDAQ), 46.59%
- Kala Pharmaceuticals, Inc. (KALA:NASDAQ), 42.7%
- Alset EHome International Inc. (AEI:NASDAQ), 37.76%
- CASI Pharmaceuticals, Inc. (CASI:NASDAQ), 37.25%
- Destiny Tech100 Inc. (DXYZ:NYSE), 33.7%
- Onconetix Inc Com (ONCO:NASDAQ), 32.19%